Editorial Board — Medscape Ophthalmology

Board Members

  • Ivan Goldberg, MBBS
    • University of Sydney
      Sydney Eye Hospital
      Sydney, Australia
  • L. Jay Katz, MD
    • Sidney Kimmel Medical College
      Thomas Jefferson University
      Wills Eye Institute
      Philadelphia, Pennsylvania
 

Board Member Details

David M. Brown, MD
David M. Brown, MD

Clinical Professor, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine; Director of Clinical Research, Retina Consultants of Houston, Houston, Texas

David M. Brown, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Genentech, Inc/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; ThromboGenics, Inc.; Allergan, Inc; Heidelberg Engineering; Optos; KOWA; Zeiss Avalanche; XOMA (US) LLC; Clearside Biomedical
Received research grant from: Genentech, Inc/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; ThromboGenics, Inc.; Allergan, Inc; Avalanche; XOMA (US) LLC; Clearside Biomedical
Received income in an amount equal to or greater than $250 from: Genentech, Inc/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; ThromboGenics, Inc.; Allergan, Inc; Avalanche; XOMA (US) LLC; Clearside Biomedical

David K. Coats, MD
David K. Coats, MD

Professor of Ophthalmology and Pediatrics/Ophthalmology, Baylor College of Medicine; Chief, Department of Ophthalmology/Ophthalmology Clinic, Texas Children's Hospital, Houston, Texas

David K. Coats, MD, has disclosed no relevant financial relationships.

H. Burkhard Dick, MD, PhD
H. Burkhard Dick, MD, PhD

H. Burkhard Dick, MD, PhD, Professor and Chairman, Center for Vision Science, Ruhr University Eye Hospital, Bochum, Germany

H. Burkhard Dick, MD, PhD, has disclosed the following relevant financial relationships:
Served as a board member (unpaid) for: Atia Medical/Shifamed, LLC; Avellino Lab USA, Inc.; Carl Zeiss Meditec; InfiniteVision Optics SAS; Medicem Group B.V.; Optical Express Inc.; Pharm-Allergan GmbH; Vivior AG; WebMD, LLC
Serve(d) as a consultant for: Avedro Inc.; Carl Zeiss Meditec; Johnson & Johnson Vision; Medicem Group B.V.; Optical Express Inc.; Polytech Domilens GmbH; RxSight, Inc.
Serve(d) as a consultant for (unpaid): AcuFocus, Inc.; Atia Medical/Shifamed, LLC; Avellino Lab USA, Inc.; Excel Lens Inc.; Oculus Inc.
Received grants paid to the institution/grants pending from: AbbVie GmbH & Co. KG; AcuFocus, Inc.; Allergan GmbH; Avedro Inc.; Bayer Healthcare AG; Carl Zeiss Meditec; F. Hoffmann-La Roche Ltd; Implandata Ophthalmic Products GmbH; Johnson & Johnson Vision; Medicem Group B.V.; Novartis Pharmaceuticals Corporation GmbH; Ophtec BV; OSD Medical GmbH; Powervision, Inc.; ROWIAK GmbH; URSAPHARM Arzneimittel GmbH
Received patents from: Abbot Laboratories; Morcher GmbH
Received royalties from: Oculus Inc.
Has stock/stock options in: AcuFocus, Inc.; Excel Lens Inc.; Implandtada Ophthalmic Products GmbH; RxSight, Inc.; Stroma Medical Corporation

Ivan Goldberg, MBBS
Ivan Goldberg, MBBS

Clinical Associate Professor, Discipline of Ophthalmology, University of Sydney; Head, Glaucoma Unit, Sydney Eye Hospital, Sydney, Australia

Ivan Goldberg, MBBS, has disclosed the following relevant financial relationships:
Serve(d) on the advisory board for: Novartis Pharmaceuticals Corporation; Allergan, Inc.
Serve(d) as a speaker or a member of a speakers bureau for: Pfizer Inc.; Novartis Pharmaceuticals Corporation
Received honoraria from: Novartis Pharmaceuticals Corporation; Allergan, Inc.; Pfizer Inc.

L. Jay Katz, MD
L. Jay Katz, MD

Director, Glaucoma Service, Wills Eye Hospital; Professor of Ophthalmology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania

L. Jay Katz, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Allergan, Inc.; Alcon Laboratories, Inc.; Glaukos; Aerie Pharmaceuticals, Inc.; Inotek Pharmaceuticals; Mati Therapeutics; Diopsys; DSM Biomedical
Serve(d) as a speaker or member of a speakers bureau for: Allergan, Inc.; Alcon Laboratories, Inc.; Glaukos; Bausch & Lomb Inc.; Aerie Pharmaceuticals, Inc.
Received research grant from: Allergan, Inc.; Alcon Laboratories, Inc; Glaukos; Aerie Pharmaceuticals, Inc.; Inotek Pharmaceuticals; Mati Therapeutics; Diopsys; Heidelberg Engineering
Has stock in: Glaukos; Mati Therapeutics; Aerie Pharmaceuticals, Inc.
Chief Medical Officer: Glaukos